User profiles for Jeffrey S. Ginsberg
jeffrey ginsbergProfessor of Medicine, McMaster University Verified email at hhsc.ca Cited by 106695 |
Accuracy of clinical assessment of deep-vein thrombosis
…, A Cogo, P Prandoni, A Girolami, JS Ginsberg - The Lancet, 1995 - Elsevier
… Dr Ginsberg is a recipient of a research scholarship from the Heart and Stroke Foundation
of Canada. We thank Mrs J Cole, Mrs S Smale, Ms D Redshaw, and Mrs L Harrison for their …
of Canada. We thank Mrs J Cole, Mrs S Smale, Ms D Redshaw, and Mrs L Harrison for their …
Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer
…, DR Anderson, M Rodger, JS Ginsberg… - Thrombosis and …, 2000 - thieme-connect.com
We have previously demonstrated that a clinical model can be safely used in a management
strategy in patients with suspected pulmonary embolism (PE). We sought to simplify the …
strategy in patients with suspected pulmonary embolism (PE). We sought to simplify the …
[HTML][HTML] A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
…, AG Turpie, D Green, JS Ginsberg… - … England Journal of …, 1999 - Mass Medical Soc
Background Patients who have a first episode of venous thromboembolism in the absence
of known risk factors for thrombosis (idiopathic thrombosis) are often treated with …
of known risk factors for thrombosis (idiopathic thrombosis) are often treated with …
Use of a clinical model for safe management of patients with suspected pulmonary embolism
PS Wells, JS Ginsberg, DR Anderson… - Annals of internal …, 1998 - acpjournals.org
Background: The low specificity of ventilation-perfusion lung scanning complicates the
management of patients with suspected pulmonary embolism. Objective: To determine the safety …
management of patients with suspected pulmonary embolism. Objective: To determine the safety …
[HTML][HTML] Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism
C Kearon, JS Ginsberg, MJ Kovacs… - … England Journal of …, 2003 - Mass Medical Soc
Background Warfarin is very effective in preventing recurrent venous thromboembolism but
is also associated with a substantial risk of bleeding. After three months of conventional …
is also associated with a substantial risk of bleeding. After three months of conventional …
Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature
WS Chan, S Anand, JS Ginsberg - Archives of internal medicine, 2000 - jamanetwork.com
Background The management of women with prosthetic heart valves during pregnancy
poses a particular challenge as there are no available controlled clinical trials to provide …
poses a particular challenge as there are no available controlled clinical trials to provide …
Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis
…, DL Lamping, M Johri, JS Ginsberg - Annals of internal …, 2008 - acpjournals.org
Background: The reason some patients with deep venous thrombosis (DVT) develop the
postthrombotic syndrome is not well understood. Objective: To determine the frequency, time …
postthrombotic syndrome is not well understood. Objective: To determine the frequency, time …
Noninvasive diagnosis of deep venous thrombosis
…, M Math, TE Newman, JS Ginsberg - Annals of internal …, 1998 - acpjournals.org
Purpose: To review noninvasive methods for diagnosis of first and recurrent deep venous
thrombosis and provide evidence-based recommendations for the diagnosis of deep venous …
thrombosis and provide evidence-based recommendations for the diagnosis of deep venous …
Risk of fatal pulmonary embolism in patients with treated venous thromboembolism
Context.—The most serious complication of deep vein thrombosis (DVT) or nonfatal pulmonary
embolism (PE) is fatal PE. However, reliable estimates as to the risk of fatal PE in patients …
embolism (PE) is fatal PE. However, reliable estimates as to the risk of fatal PE in patients …
Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
This chapter about the use of antithrombotic agents during pregnancy is part of the Seventh
ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines…
ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based Guidelines…